Endoluxe, Mayo Clinic partner on AI research

Imaging company Endoluxe has entered into a know-how agreement with Rochester, Minn.- based Mayo Clinic to research the uses of artificial intelligence and machine learning in the treatment of bladder cancer.

Advertisement

Through the agreement, Mayo Clinic will use the Endoluxe Visualization System, a tool that utilizes AI to provide clinicians with data during surgical procedures, and in turn Endoluxe will use the insights gained to advance development of its platform, according to a Dec. 5 Endoluxe news release. 

Endoluxe designs its video platforms to be vendor agnostic.

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.